UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000021034
Receipt No. R000024274
Official scientific title of the study Vaginal chloramphenicol transfer to blood in pregnant women and its relationship with maternal and neonatal infant's factors
Date of disclosure of the study information 2016/02/15
Last modified on 2017/02/14 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Vaginal chloramphenicol transfer to blood in pregnant women and its relationship with maternal and neonatal infant's factors
Title of the study (Brief title) Vaginal chloramphenicol transfer to blood in pregnant women and its relationship with maternal and neonatal infant's factors
Region
Japan

Condition
Condition bacterial vaginosis
Classification by specialty
Obsterics and gynecology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study aimed to evaluate the plasma concentration in pregnant women treated with vaginal chloramphenicol and its relationship with maternal and her infant factors
Basic objectives2 Pharmacokinetics
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Maternal plasma concentration of chloramphenicol
Key secondary outcomes Factors determining the plasma exposure of chloramphenicol
Effect of maternal plasma concentration of chloramphenicol on her infants

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria 1.Patients receiving trans-vaginal chloramphenicol during pregnancy for bacterial vaginosis
2.Patients receiving written informed consent
Key exclusion criteria 1.Patients discontinued trans-vaginal chloramphenicol
2.Patients having severe kidney dysfunction or liver dysfunction
Target sample size 50

Research contact person
Name of lead principal investigator Junichi Kawakami
Organization Hamamatsu University School of Medicine
Division name Department of Hospital Pharmacy
Address 1-20-1 Handayama, Hamamatsu 431-3192, Japan
TEL 053-435-2762
Email Pharmacyham-adm@umin.ac.jp

Public contact
Name of contact person Takafumi Naito
Organization Hamamatsu University School of Medicine
Division name Department of Hospital Pharmacy
Address 1-20-1 Handayama, Hamamatsu 431-3192, Japan
TEL 053-435-2623
Homepage URL
Email Pharmacyham-adm@umin.ac.jp

Sponsor
Institute Department of Hospital Pharmacy Hamamatsu University School of Medicine
Institute
Department

Funding Source
Organization Department of Hospital Pharmacy Hamamatsu University School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 02 Month 15 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 02 Month 21 Day
Anticipated trial start date
2014 Year 02 Month 28 Day
Last follow-up date
2017 Year 02 Month 28 Day
Date of closure to data entry
2017 Year 02 Month 28 Day
Date trial data considered complete
2017 Year 02 Month 28 Day
Date analysis concluded
2017 Year 02 Month 28 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Study design: Cohort study

Object recruitment: Patients receiving trans-vaginal chloramphenicol during pregnancy for bacterial vaginosis from April 2014 to March 2017

Primary outcome: Maternal plasma concentration of chloramphenicol

Secondary outcome:
Factors determining the plasma exposure of chloramphenicol such as hepatic and urine function
Effect of maternal plasma concentration of chloramphenicol on her infants

Management information
Registered date
2016 Year 02 Month 15 Day
Last modified on
2017 Year 02 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024274